domperidone and carbostyril

domperidone has been researched along with carbostyril in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19901 (20.00)18.7374
1990's3 (60.00)18.2507
2000's0 (0.00)29.6817
2010's1 (20.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Momiyama, T; Sasa, M; Takaori, S1
Ohno, Y; Sasa, M; Takaori, S1
Amano, T; Momiyama, T; Sasa, M; Todo, N1
Amano, T; Matsubayashi, H; Sasa, M1
Calas, AG; Goursaud, S; Hermans, E; Jeanjean, AP; Koener, B; Maloteaux, JM; Van De Stadt, M1

Other Studies

5 other study(ies) available for domperidone and carbostyril

ArticleYear
D-2 receptor-mediated inhibition by a substituted quinolinone derivative, 7-[3-(4-(2,3-dimethylphenyl)piperazinyl)propoxy]-2(1H)-quinolinone (OPC-4392), of dopaminergic neurons in the ventral tegmental area.
    Life sciences, 1990, Volume: 47, Issue:9

    Topics: Animals; Benzazepines; Domperidone; Dopamine; Dopamine Agents; Electric Stimulation; Male; Neurons; Nucleus Accumbens; Piperazines; Quinolones; Rats; Rats, Inbred Strains; Receptors, Dopamine; Receptors, Dopamine D2; Tegmentum Mesencephali

1990
Presynaptic inhibition of excitatory input from the substantia nigra to caudate nucleus neurons by a substituted quinolinone derivative, 7-[3-(4-(2,3-dimethylphenyl)piperazinyl)propoxy]-2(1H)-quinolinone (OPC-4392).
    Life sciences, 1988, Volume: 43, Issue:3

    Topics: Action Potentials; Animals; Bromocriptine; Cats; Caudate Nucleus; Domperidone; Dopamine; Electric Stimulation; Neural Pathways; Neurons; Piperazines; Quinolines; Quinolones; Sodium Glutamate; Substantia Nigra

1988
Inhibition by a putative antipsychotic quinolinone derivative (OPC-14597) of dopaminergic neurons in the ventral tegmental area.
    European journal of pharmacology, 1996, Aug-22, Volume: 310, Issue:1

    Topics: Animals; Antipsychotic Agents; Aripiprazole; Benzazepines; Domperidone; Dopamine Antagonists; In Vitro Techniques; Male; Piperazines; Quinolones; Rats; Rats, Wistar; Ventral Tegmental Area

1996
Inhibition by aripiprazole of dopaminergic inputs to striatal neurons from substantia nigra.
    Psychopharmacology, 1999, Volume: 146, Issue:2

    Topics: Animals; Antipsychotic Agents; Aripiprazole; Domperidone; Dopamine; Dopamine Antagonists; Electric Stimulation; Electrophysiology; Evoked Potentials; Extracellular Space; Male; Microelectrodes; Neostriatum; Neurons; Piperazines; Quinolones; Rats; Rats, Wistar; Substantia Nigra

1999
Pharmacological blockade of dopamine D2 receptors by aripiprazole is not associated with striatal sensitization.
    Naunyn-Schmiedeberg's archives of pharmacology, 2011, Volume: 383, Issue:1

    Topics: Animals; Apomorphine; Aripiprazole; Buffers; Catalepsy; Cell Membrane; Cerebral Cortex; Corpus Striatum; Domperidone; Dopamine; Dopamine Agonists; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Drug Antagonism; Drug Partial Agonism; Guanosine 5'-O-(3-Thiotriphosphate); Haloperidol; Hippocampus; Male; Piperazines; Piperidines; Pyridines; Quinolones; Rats; Rats, Wistar; Receptors, Dopamine D2; Receptors, Serotonin, 5-HT1; Serotonin; Serotonin 5-HT1 Receptor Antagonists; Stereotyped Behavior; Up-Regulation

2011